Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.
暂无分享,去创建一个
Janice N Cormier | Kelly K Hunt | G. Hortobagyi | K. Hunt | T. Buchholz | A. Buzdar | A. Sahin | S. Tucker | E. Mittendorf | A. González-Angulo | J. Cormier | J. Jeruss | Gabriel N Hortobagyi | Ana M Gonzalez-Angulo | Aysegul A Sahin | Thomas A Buchholz | Aman U Buzdar | Susan L Tucker | Jacqueline S Jeruss | Elizabeth A Mittendorf
[1] L. Carey,et al. Size of Residual Lymph Node Metastasis After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients Is Prognostic , 2006, Annals of Surgical Oncology.
[2] D. Cox. Regression Models and Life-Tables , 1972 .
[3] R. Simon,et al. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. , 1978, The New England journal of medicine.
[4] G. Hortobagyi,et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] G. Hortobagyi,et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] L. Carey,et al. American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome. , 2005, Journal of the National Cancer Institute.
[7] A. Luini,et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. , 1990, Journal of the National Cancer Institute.
[8] Anna L. Brown,et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] J. Torhorst,et al. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] G. Hortobagyi,et al. A new measurement of residual cancer burden to predict survival after neoadjuvant chemotherapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[12] L. Carey,et al. Long-Term Outcome of Neoadjuvant Therapy for Locally Advanced Breast Carcinoma: Effective Clinical Downstaging Allows Breast Preservation and Predicts Outstanding Local Control and Survival , 2002, Annals of surgery.
[13] M. Goodell,et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] L. Newman,et al. Histopathologic Evidence of Tumor Regression in the Axillary Lymph Nodes of Patients Treated With Preoperative Chemotherapy Correlates With Breast Cancer Outcome , 2003, Annals of Surgical Oncology.
[15] G. Hortobagyi,et al. Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] H. B. Mann,et al. On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .
[17] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[18] G. Bonadonna,et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] P. Ellis,et al. Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] K. Hunt,et al. Proposed Revision of the Esophageal Cancer Staging System to Accommodate Pathologic Response (pP) Following Preoperative Chemoradiation (CRT) , 2005, Annals of surgery.
[21] Christine Desmedt,et al. Proliferation: the Most Prominent Predictor of Clinical Outcome in Breast Cancer , 2006, Cell cycle.
[22] Roman Rouzier,et al. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] W. S. Lazarus-Barlow,et al. THE NATURAL DURATION OF CANCER , 1924, British medical journal.
[24] J. Bryant,et al. Pathobiology of preoperative chemotherapy , 2002 .
[25] G. Hortobagyi,et al. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] R. Scolyer,et al. Survival in patients with desmoplastic melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Roman Rouzier,et al. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.
[28] G. Hortobagyi,et al. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] G. Hortobagyi,et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. , 1998, American journal of surgery.
[30] G. Hortobagyi,et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. , 1999, Annals of surgery.
[31] D. Wickerham,et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.